Year : 2018 | Volume
: 30 | Issue : 1 | Page : 12--16
Lakshmi Sravani Mandava, Ganesh V Raman
Department of Glaucoma, Aravind Eye Hospital, Coimbatore, Tamil Nadu, India
Ganesh V Raman
Glaucoma Clinic, Aravind Eye Hospital, Avinashi Road, Coimbatore - 641 014, Tamil Nadu
In India primary angle closure disease comprises approximately fifty percent of primary glaucoma. It is the leading cause of blindness from glaucoma. Appropriate identification and institution of therapy can prevent long term morbidity from this disease. The use of Pilocarpine and the application of laser iridotomy early in the treatment of angle closure glaucoma has to be underscored. Long term prognosis depends upon identification of the variety of presentations and appropriate use of medical and laser and surgical therapy to maintain a good quality of life for the patients. Family screening plays an important role in detecting new patients at an early stage of the disease.
|How to cite this article:|
Mandava LS, Raman GV. Angle-closure glaucoma.Kerala J Ophthalmol 2018;30:12-16
|How to cite this URL:|
Mandava LS, Raman GV. Angle-closure glaucoma. Kerala J Ophthalmol [serial online] 2018 [cited 2021 Sep 26 ];30:12-16
Available from: http://www.kjophthal.com/text.asp?2018/30/1/12/233779
Angle-closure glaucoma is considered as the leading cause of irreversible blindness worldwide and the incidence of primary angle-closure glaucoma (PACG) is higher in Asians. It is estimated that about 15 million people worldwide have been affected by angle-closure disease in 2010 and the number is expected to increase to 21 million by 2020.
Tham et al. estimated that the number of people that will be affected with PACG worldwide would be 23.36 million and 32.04 million in 2020 and 2040, respectively. Similarly, in Asians, it would be 17.96 million and 24.5 million, respectively.
Age: Increased frequency with advancing age Gender: 2–3 times more common in women Ethnicity: Asians, more common in Chinese Family history of angle closure Refractive error: Prevalence is higher in individuals with hyperopic eyes Shallow anterior chamber depth Shorter axial lengthhicker lens.
Definition and Classification
Angle-closure disease has two forms: Primary and secondary.
The primary angle closure disease (PACD) according to the natural history is classified based on the definition proposed by the International Society for Geographical and Epidemiological Ophthalmology as.
Primary angle-closure suspect
The presence of iridotrabecular contact for at least 270° on gonioscopy (with the eye in the primary position, without indentation), with normal intraocular pressure (IOP), optic disc, and visual fields.
Primary angle closure
The presence of iridotrabecular contact for at least 270°, with either raised IOP and/or peripheral anterior synechiae (PAS), but with normal optic disc and visual fields. Other signs which suggest PAC include loss of pupillary riff, iris whorling, glaukomflecken, and endothelial cell damage.
Primary angle-closure glaucoma
The presence of iridotrabecular contact for >270°, with raised IOP and optic nerve and visual field damage. Some authors modify and even take >180° of iridotrabecular contact as an indication for intervention.
Primary angle-closure disease is classified based on the mechanism of closure into:
Iris–pupil obstruction (e.g., pupillary block)Ciliary body anomalies (e.g., plateau iris syndrome)Phacomorphic mechanismThick iris/thick last peripheral roll of iris induced angle closure.
In majority of cases, primary angle closure is caused by relative pupillary block, in which aqueous encounters increased resistance as it flows from the posterior to anterior chamber. The risk of pupillary block is high in a mid-dilated pupil as there is maximum contact between the iris and the lens. The increased pressure gradient across the pupil causes the peripheral iris to bow forward and cover the filtering portion of the trabecular meshwork, leading to appositional angle closure. Prolonged and repeated contact between the peripheral iris and trabecular meshwork leads to PAS formation.
A less common cause of primary angle closure is plateau iris configuration. It is characterized by a normal central anterior chamber depth, flat iris plane, and crowding of the angle by the iris base as it is displaced forward by anteriorly located ciliary processes. This can lead to subsequent angle closure.
Secondary angle closure
It is caused by an underlying identifiable pathologic event. When associated with elevated IOP and glaucomatous disc damage, it is referred to as secondary angle-closure glaucoma. The underlying causes are listed below according to the pathophysiology of obstruction.
Anterior “pulling mechanism”
The iris is pulled forward by some process in the angle, often by the contraction of a membrane or PAS.
Neovascular glaucomaIridocorneal endothelial syndromes (e.g., Chandler's syndrome)Epithelial downgrowthFibrous ingrowthFlat anterior chamberInflammationPenetrating keratoplasty.
Posterior “pushing mechanism”
The iris is pushed forward by some condition in the posterior segment. Often, the ciliary body is rotated anteriorly, allowing the lens to come forward also.
Malignant glaucomaCysts of the iris and ciliary bodyIntraocular tumors, silicone oil, or gasNanophthalmosDrug induced (e.g., systemic topiramate)Suprachoroidal hemorrhage, choroidal effusionScleral buckleAnteriorly displaced lensContracting retrolental tissue as seen in retinopathy of prematurity.
Acute attack of primary angle-closure glaucoma
Signs and symptoms
The typical patient with an acute attack of PACG from the papillary block will have a sudden onset of pain or aching on the side of the affected eye. The eye pain appears to be related more to the rapid rate of the rise in IOP than to the absolute level of the pressure itself. This pain is accompanied by blurred vision or colored haloes around lights and ocular congestion. Autonomic stimulation during an acute attack can result in nausea, vomiting, sweating, and bradycardia.
Diminished visual acuityCircumcorneal conjunctival congestionCorneal edema, usually involving only the epithelium, but occasionally thickening the stroma alsoA shallow anterior chamber both centrally and peripherallyMinimal anterior chamber reaction caused by increased aqueous humor protein concentrationA moderately dilated, vertically oval, sluggish, or nonreactive pupil as the high IOP causes ischemia and paresis of the pupillary sphincterMarkedly elevated IOP, usually in the range of 35–75 mmHgA closed angle on gonioscopy, which is the critical test for diagnosing angle-closure glaucoma. It is sometimes difficult to evaluate the angle during an acute attack because of corneal edema and hazy media. In this situation, gonioscopy should be repeated after the IOP is reduced by medical treatmentSometimes a hyperemic, swollen optic disc is seen probably from impaired axoplasmic flow.
The rationale of treatment, once angle closure has been diagnosed, is to:
Eliminate pupillary blockAssess the extent of angle closureDocument baseline features following iridotomy in terms of goniosopy, optic disc, and visual field assessmentFollow-up in terms of IOP monitoring, progression of angle closure, disc, and field changesProtection of the fellow eye.
Various provocative tests have been developed to find out patients who may be at higher risk of angle closure. The test is considered positive if the IOP increases by 8 mmHg or more. Commonly used tests are as follows:
Dark-room test – the patients are placed in a dark room for 1–2 h to dilate the pupil and increase resistance at iris–lens diaphragmProne test – the patient is placed in prone position for 1–2 h to displace the lens anteriorly and increase pupillary blockMydriatic provocative test – causes pupillary dilatation and increase pupillary block.
However, these tests are not found to be very predictive of angle closure.
These provide detailed images of various structures and also help in quantitative measurements. They are useful in detecting both primary and secondary cases of angle closure.
Ultrasound biomicroscopy: It is a high-frequency B scan ultrasound which provides high-resolution cross-sectional images of the anterior segment of the eye up to the anterior vitreous. It is particularly useful in evaluating plateau iris and any pathology related to the ciliary body Anterior segment optical coherence tomography: It utilizes diode light source to produce detailed images of cornea, angle, and anterior ciliary body. However, it is unable to image structures posterior to the iris.
Medical management of acute primary angle-closure glaucoma
Patient comfort and lowering of the IOP are the first priorities in managing an acute crisis of PACG. When these are achieved, one can proceed to more definitive interventions with the laser, such as iridotomy, pupilloplasty, or iridoplasty.
Topical anti-glaucoma medications which can be used are topical beta-blocker (timolol maleate 0.5% bid), topical carbonic anhydrase inhibitors (dorzolamide 2% bid/brinzolamide 1%). Pilocarpine 2% tid can also be used and should be used once treatment for the acute phase of IOP is initiated. Alpha-adrenergic agonist (brimonidine 0.15%–0.2%) may also be used, but personally, I avoid it because of its mydriatic property.
Oral carbonic anhydrase inhibitors such as acetazolamide 500 mg is given in tid dosage. If the patient is nauseous, intravenous acetazolamide 250–500 mg can be given.
Systemic hyperosmotic agents dehydrate the vitreous and allow the lens–iris diaphragm to move posteriorly. They are often the most effective means of lowering IOP during acute episodes of angle-closure glaucoma.
Oral glycerin is administered as a 50% solution in a dose of 1.5–4 ml/kg. In diabetes patients, oral 45% isosorbide solution can be given in a similar dose.
If the patient is nauseous or vomiting, 20% mannitol is administered in a dose of 2.0–7 ml/kg over 30–45 min. It is to be used with caution as it may induce cardiac overload, especially in elderly patients with cardiovascular disease.
In most acute attacks of angle-closure glaucoma with pupillary block, the high IOP leads to ischemia of the pupillary sphincter muscle making it unresponsive to topical miotics. Therefore, pilocarpine is by itself less likely to bring down the high pressure of an acute attack. Pilocarpine still remains the drug of choice in angle-closure glaucoma and is to be used with simultaneous efforts to bring down the raised IOP or after bringing down the raised IOP.
To reduce anterior chamber inflammation and the chance of both anterior and posterior synechiae formation, topical steroids are to be used.
Once adequate lowering of IOP has been achieved and intraocular inflammation has subsided, laser peripheral iridotomy (LPI) or surgical iridectomy is be performed. It is imperative to perform laser iridotomy in the fellow eye as the prognosis of the eye with acute attack is guarded, and the fellow eye has been known to progress to chronic glaucoma and resultant blindness if left untreated.
Laser peripheral iridotomy
Peripheral laser iridotomy with Nd:YAG or Argon laser is the definitive treatment for acute angle-closure glaucoma with the pupillary block. It establishes free communication between the posterior and anterior chambers, and there is an insufficient pressure differential to push the peripheral iris forward against the trabecular meshwork. The peripheral anterior chamber depth usually increases after iridotomy, in the absence of extensive PAS, whereas the central depth is unchanged.
Although surgical iridectomy is a relatively safe and simple procedure, it is invasive and presents a small risk of intraocular complications such as bleeding, cataract, and endophthalmitis. Surgical iridectomy is now reserved for such infrequent situations such as the laser fails to produce a patent iridotomy, laser iridotomy repeatedly closes, a laser is neither available nor functioning properly, opacities of the cornea interfere with laser treatment, or the patient is uncooperative or unable to sit at the slit lamp.
Laser iridoplasty and pupilloplasty
The peripheral iridoplasty is a usually done in the following settings:
Acute PACG from pupillary block, unresponsive to medical treatment, and where a laser iridotomy is precluded by excessive shallowing of the anterior chamber, inflammation or corneal edema ,Plateau iris syndrome andAcute phacomorphic angle closure.
In laser iridoplasty, burns of long duration and low power are placed on the peripheral iris which contracts the iris and physically pulls the iris away from the angle in an attempt to open the angle. It is only useful in short-term lowering of IOP and does not relieve pupillary block. It is the treatment of choice in plateau iris syndrome where peripheral iridotomy is not helpful.
Pupilloplasty refers to a laser technique which can interrupt pupillary block by distorting the pupil into a tear-shaped configuration by applications of intense, small bursts of argon laser 2–3 mm eccentric to the pupillary margin superiorly, thus facilitating aqueous flow into the anterior chamber.
Surgical management of primary angle-closure glaucoma
Lens extraction: It is believed that increasing lens thickness and relative anterior lens position may be responsible for the crowding of the angle, and this may be ameliorated by removing the crystalline lens and implanting an intraocular lens. However, the surgeon may face with intra-operative challenges such as a shallow anterior chamber, a convex lens prone to anterior capsular tears, and a flaccid iris from ischemic damage. Although according to EAGLE study, clear lens extraction showed greater efficacy and was more cost-effective than LPI, the IOP reduction was found insufficient in the long term and the general consensus was that lens extraction may be useful in population where access to glaucoma services is sporadic Trabeculectomy: In patients unresponsive to medical treatment, especially if residual PAS extending to >180° is present, laser therapy in the setting of an acute attack may not be possible. In such situation, trabeculectomy may provide an alternative solution. It is also useful when signs of disc damage are already present. However, this is associated with a high risk of surgical failure and complications., Combined cataract with filtration surgery and cataract with glaucoma drainage device can also be attempted. In a study by Tsai et al., in patients with PACG, the long-term IOP-lowering effect and surgical complications of combined trabeculectomy and cataract extraction are comparable with those of trabeculectomy alone. However, the combined surgery incurred fewer subsequent surgical interventions Goniosynechialysis: It refers to the deliberate intra-operative shearing or peeling of synechial adhesions in the angle, either mechanically using forceps or cyclodialysis spatula or with a viscoelastic dissection, for at least 180°.
Management of the fellow eye
Fellow eye of an eye presenting with acute PACG requires a laser iridotomy as most of these eyes steadily progress through the natural history of the condition, unless that course is interrupted. In Asian population with acute PAC, prophylactic laser iridotomy is safe and effective in preventing acute angle closure in fellow eyes. The rate of progression in primary angle closure suspect (PACS) is slower compared to PAC. According to the Chennai eye disease incidence study, there was significant cataract progression in 6 years following LPI in PACS. Hence, the decision to treat PACS should be taken after carefully evaluating the risk and benefit in that particular patient.
Due to the high prevalence and morbidity associated with angle-closure glaucoma, there is a need for screening methods. At the community level, evaluation of the anterior chamber depth can be done using flashlight, where light is held from the temporal side and the shadow projected onto the nasal iris is observed. The presence of this shadow indicates a shallow anterior chamber as the iris is bowing forward and blocking the light pathway. The absence of this shadow indicates an open angle.
Pupillary reaction can be assessed and a relative afferent pupillary defect can be noticed in advanced glaucoma.
On slit-lamp examination by a general ophthalmologist, the anterior chamber depth can be assessed using Van Herick method, where a narrow slit is projected just adjacent to the limbus and the distance between the anterior surface of the iris and the posterior surface of cornea is compared to that of the corneal thickness.
Screening of the family members of patients with glaucoma is also necessary. In the South Indian population screened, siblings of angle closure patients had a >1 in 3 risk of prevalent angle closure, whereas siblings of PAC/PACG patients had a >10% risk of prevalent PAC/PACG.
Secondary angle closure
Diagnosis of primary or secondary angle closure is based on the history and clinical examination.
In secondary cases, a clue to the diagnosis can be obtained by taking detailed ocular and systemic history regarding trauma, previous intraocular surgery, laser, history of diabetes, hypertension, carotid stenosis, and use of systemic medications like topiramate.
On examination, one should look for signs of trauma, anterior chamber reaction, iris lesions, neovascularization, lens status and position, posterior segment vascular changes, intraocular tamponade agents, scleral buckle, etc.
Treatment of secondary angle closure is aimed at primarily treating the causative factor as well as controlling IOP.
Angle-closure glaucoma is the most common cause of hospital-based blindness due to glaucoma. Comprehensive examination by the ophthalmologist and serial gonioscopic examination in cases of suspects will go a long way in controlling blindness due to this disease. Appropriate management of acute glaucoma with immediate laser iridotomy (or surgical iridectomy) helps relieve symptoms of acute attack, preserves vision, and establishes better doctor–patient relationship. Opportunistic screening of family members is now the only cost-effective method to detect new patients of PACD.
Dr. Shabana Bharathi, Ex Glaucoma Fellow, Aravind Eye Hospital, Coimbatore.Dr. Mrunali Dhavaliker, Medical Officer, Department of Glaucoma, Aravind Eye Hospital, Coimbatore.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
|1||Wong TY, Loon SC, Saw SM. The epidemiology of age related eye diseases in Asia. Br J Ophthalmol 2006;90:506-11.|
|2||Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006;90:262-7.|
|3||Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis. Ophthalmology 2014;121:2081-90.|
|4||Hillman JS. Acute closed-angle glaucoma: An investigation into the effect of delay in treatment. Br J Ophthalmol 1979;63:817-21.|
|5||Cheng JW, Zong Y, Zeng YY, Wei RL. The prevalence of primary angle closure glaucoma in adult Asians: A systematic review and meta-analysis. PLoS One 2014;9:e103222.|
|6||Perkins ES. Family studies in glaucoma. Br J Ophthalmol 1974;58:529-35.|
|7||Lowe RF. Aetiology of the anatomical basis for primary angle-closure glaucoma. Biometrical comparisons between normal eyes and eyes with primary angle-closure glaucoma. Br J Ophthalmol 1970;54:161-9.|
|8||Van Herick W, Shaffer RN, Schwartz A. Estimation of width of angle of anterior chamber. Incidence and significance of the narrow angle. Am J Ophthalmol 1969;68:626-9.|
|9||Lowe RF. Causes of shallow anterior chamber in primary angle-closure glaucoma. Ultrasonic biometry of normal and angle-closure glaucoma eyes. Am J Ophthalmol 1969;67:87-93.|
|10||Foster PJ, Buhrmann R, Quigley HA, Johnson GJ. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol 2002;86:238-42.|
|11||Wilensky JT, Kaufman PL, Frohlichstein D, Gieser DK, Kass MA, Ritch R, et al. Follow-up of angle-closure glaucoma suspects. Am J Ophthalmol 1993;115:338-46.|
|12||Garcia JP Jr., Rosen RB. Anterior segment imaging: Optical coherence tomography versus ultrasound biomicroscopy. Ophthalmic Surg Lasers Imaging 2008;39:476-84.|
|13||Lim AS, Tan A, Chew P, Seah S, Min G, Yee T, et al. Laser iridoplasty in the treatment of severe acute angle closure glaucoma. Int Ophthalmol 1993;17:33-6.|
|14||Lam DS, Lai JS, Tham CC, Chua JK, Poon AS. Argon laser peripheral iridoplasty versus conventional systemic medical therapy in treatment of acute primary angle-closure glaucoma: A prospective, randomized, controlled trial. Ophthalmology 2002;109:1591-6.|
|15||Azuara-Blanco A, Burr J, Ramsay C, Cooper D, Foster PJ, Friedman DS, et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): A randomised controlled trial. Lancet 2016;388:1389-97.|
|16||Aung T, Tow SL, Yap EY, Chan SP, Seah SK. Trabeculectomy for acute primary angle closure. Ophthalmology 2000;107:1298-302.|
|17||Chen YH, Lu DW, Cheng JH, Chen JT, Chen CL. Trabeculectomy in patients with primary angle-closure glaucoma. J Glaucoma 2009;18:679-83.|
|18||Tsai HY, Liu CJ, Cheng CY. Combined trabeculectomy and cataract extraction versus trabeculectomy alone in primary angle-closure glaucoma. Br J Ophthalmol 2009;93:943-8.|
|19||Teekhasaenee C, Ritch R. Combined phacoemulsification and goniosynechialysis for uncontrolled chronic angle-closure glaucoma after acute angle-closure glaucoma. Ophthalmology 1999;106:669-74.|
|20||Edwards RS. Behaviour of the fellow eye in acute angle-closure glaucoma. Br J Ophthalmol 1982;66:576-9.|
|21||Ang LP, Aung T, Chew PT. Acute primary angle closure in an Asian population: Long-term outcome of the fellow eye after prophylactic laser peripheral iridotomy. Ophthalmology 2000;107:2092-6.|
|22||Vijaya L, Asokan R, Panday M, George R. Is prophylactic laser peripheral iridotomy for primary angle closure suspects a risk factor for cataract progression? The Chennai eye disease incidence study. Br J Ophthalmol 2017;101:665-70.|
|23||Kavitha S, Zebardast N, Palaniswamy K, Wojciechowski R, Chan ES, Friedman DS, et al. Family history is a strong risk factor for prevalent angle closure in a South Indian population. Ophthalmology 2014;121:2091-7.|